Watch for new payment when you perform HPV testing during cancer screening

Why This Topic Matters

The update affects how practices think about cervical cancer screening workflows, Medicare-covered preventive services, and future claims processing guidance. It is relevant for organizations that perform screening, send specimens to labs, or educate patients about HPV testing and Pap smear co-testing.

Article Sections

1. Medicare coverage update and screening context

   This section introduces the Medicare coverage change and describes the general screening setting in which HPV testing is being discussed. It frames the article around cervical cancer prevention and primary care implementation.

2. Laboratory and workflow considerations

   This section discusses how practices may need to coordinate with laboratories and adjust office processes when adding HPV testing to screening visits. It focuses on operational readiness rather than technical coding details.

3. CMS screening guidelines and pending coding guidance

   This section summarizes the broad CMS screening parameters described in the article and notes that coding and billing specifications were still pending. It also points readers to additional CMS guidance sources.

4. Pap smear preventive service codes

   This section identifies preventive Pap smear service codes mentioned as potentially relevant to the screening workflow. It presents them in the context of Medicare preventive services and pricing references.

5. Get familiar with HPV to boost compliance

   This section shifts to patient education and screening compliance, emphasizing communication about HPV and cervical cancer screening. It highlights the importance of clear patient-facing explanations and awareness of screening participation.